Sometime in the 1980s, the emerging infectious disease (EID) movement began. The "emerging" label had been used earlier, but a series of high-profile disease outbreaks in the 1980s, combined with perceived funding gaps, began to galvanize the field. A book by Richard Krause of the National Institutes of Health1 formed part of the initial thrust. Published in the same year as the recognition of AIDS, it commented on the alarming phenomenon of antibiotic-resistant microbes. Further threats surfac
 |
The year 1992 saw the publication of an Institute of Medicine treatise on emerging infections,2 and a special section in Science talked about a "post-antimicrobial era," tuberculosis as a "reemergent killer," and the "crisis in antibiotic resistance." This was rapidly followed by Emerging Viruses3 by Stephen S. Morse of Rockefeller University, and another Science section included ...
Add The Scientist as a preferred Google source to see more of our trusted coverage.
When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.
View this Issue
Explore strategies for improving recombinant adeno-associated virus production in transient HEK293 suspension cultures while maintaining vector quality and supporting scalable viral vector manufacturing.
Discover how tissue-resident memory T cells develop within the respiratory tract and how these findings are advancing respiratory virus immunity, vaccine research, and high-throughput immune profiling.
Explore emerging mechanisms of immune checkpoint inhibitor resistance in hepatocellular carcinoma (HCC) and how combination immunotherapy strategies may improve antitumor immune responses and patient-specific treatment approaches.
Learn practical strategies for optimizing sample preparation, fragmentation, library construction, and quality control to generate high-quality next-generation sequencing (NGS) data across a range of sample types.
European customers can now subscribe to Sino Biological’s newsletter to receive a special gift and unlock access to EliteScience benefits.
Sino Biological’s trial program enables qualified customers to evaluate SuperNuclease Pro in their specific bioprocessing applications, facilitating faster technology assessment and informed decision-making during process development
This release expands on Sino Biological's comprehensive Tau protein product portfolio, designed to accelerate neurodegenerative disease research.
Resipher measures cellular respiration (OCR) continuously in standard 96-well plates inside your incubator, for days to weeks. No media swaps, dyes, or transfers. A live-cell functional readout for drug safety, metabolism, and mitochondrial health.
